O'Keefe Stevens Advisory’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $437K | Hold |
1,875
| – | – | 0.09% | 58 |
|
|
2026
Q2 | $397K | Hold |
1,875
| – | – | 0.08% | 60 |
|
|
2026
Q1 | $367K | Hold |
1,875
| – | – | 0.09% | 60 |
|
|
2025
Q4 | $325K | Hold |
1,875
| – | – | 0.08% | 54 |
|
|
2025
Q3 | $357K | Sell |
1,875
-625
| -25% | -$111K | 0.1% | 53 |
|
|
2025
Q2 | $449K | Hold |
2,500
| – | – | 0.13% | 51 |
|
|
2025
Q1 | $423K | Hold |
2,500
| – | – | 0.14% | 49 |
|
|
2024
Q4 | $377K | Hold |
2,500
| – | – | 0.12% | 55 |
|
|
2024
Q3 | $388K | Hold |
2,500
| – | – | 0.12% | 55 |
|
|
2024
Q2 | $342K | Hold |
2,500
| – | – | 0.11% | 45 |
|
|
2024
Q1 | $333K | Hold |
2,500
| – | – | 0.11% | 40 |
|
|
2023
Q4 | $345K | Hold |
2,500
| – | – | 0.14% | 37 |
|
|
2023
Q3 | $305K | Hold |
2,500
| – | – | 0.14% | 34 |
|
|
2023
Q2 | $351K | Hold |
2,500
| – | – | 0.15% | 35 |
|
|
2023
Q1 | $354K | Hold |
2,500
| – | – | 0.17% | 31 |
|
|
2022
Q4 | $391K | Hold |
2,500
| – | – | 0.23% | 30 |
|
|
2022
Q3 | $307K | Hold |
2,500
| – | – | 0.21% | 30 |
|
|
2022
Q2 | $332K | Hold |
2,500
| – | – | 0.2% | 30 |
|
|
2022
Q1 | $342K | Hold |
2,500
| – | – | 0.17% | 29 |
|
|
2021
Q4 | $433K | Hold |
2,500
| – | – | 0.2% | 31 |
|
|
2021
Q3 | $363K | Hold |
2,500
| – | – | 0.2% | 33 |
|
|
2021
Q2 | $330K | Hold |
2,500
| – | – | 0.18% | 33 |
|
|
2021
Q1 | $319K | Hold |
2,500
| – | – | 0.2% | 31 |
|
|
2020
Q4 | $298K | Hold |
2,500
| – | – | 0.2% | 35 |
|
|
2020
Q3 | $286K | Hold |
2,500
| – | – | 0.22% | 35 |
|
|
2020
Q2 | $285K | Buy |
+2,500
| New | +$265K | 0.25% | 30 |
|
|
2019
Q4 | $264K | Hold |
2,500
| – | – | 0.2% | 36 |
|
|
2019
Q3 | $268K | Hold |
2,500
| – | – | 0.21% | 37 |
|
|
2019
Q2 | $255K | Hold |
2,500
| – | – | 0.19% | 38 |
|
|
2019
Q1 | $225K | Hold |
2,500
| – | – | 0.17% | 38 |
|
|
2018
Q4 | $208K | Hold |
2,500
| – | – | 0.19% | 37 |
|
|
2018
Q3 | $270K | Hold |
2,500
| – | – | 0.19% | 36 |
|
|
2018
Q2 | $275K | Hold |
2,500
| – | – | 0.22% | 33 |
|
|
2018
Q1 | $251K | Hold |
2,500
| – | – | 0.22% | 40 |
|
|
2017
Q4 | $246K | Hold |
2,500
| – | – | 0.22% | 39 |
|
|
2017
Q3 | $234K | Buy |
+2,500
| New | +$265K | 0.22% | 41 |
|
Other funds holding DGX
O'Keefe Stevens Advisory's DGX Position: Q3 2026 in Review
O'Keefe Stevens Advisory held its Quest Diagnostics (DGX) position steady in Q3 2026 at 1,875 shares worth $437K. The position accounts for 0.09% of the portfolio, ranked #58.
O'Keefe Stevens Advisory first reported a position in DGX in Q3 2017 and has held it in 36 quarters since. The position peaked at $449K in Q2 2025. 414 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- O'Keefe Stevens Advisory held 1,875 shares of Quest Diagnostics worth $437K as of Q3 2026.
- O'Keefe Stevens Advisory left its Quest Diagnostics share count unchanged in Q3 2026.
- Quest Diagnostics made up 0.09% of O'Keefe Stevens Advisory's portfolio in Q3 2026, its #58 holding.
- O'Keefe Stevens Advisory first reported a position in Quest Diagnostics in Q3 2017 and has held it in 36 quarters since.
- O'Keefe Stevens Advisory's Quest Diagnostics position peaked at $449K in Q2 2025.
- 414 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on O'Keefe Stevens Advisory's 13F filing for Q3 2026, filed 9 Oct 2026.